Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 76485

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2023 | Month : May | Volume : 17 | Issue : 5 | Page : PF01 - PF06 Full Version

Preoperative Single Dose Intraincisional vs Intravenous Ceftriaxone in Preventing Surgical Site Infection Post-Hernioplasty Conducted at a Tertiary Care Centre at Chengalpattu, Tamil Nadu, India


Published: May 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/60685.17732
A Pravindhas, K Navaneetha, A Ajay Raja, R Lakshmana, Neethish K Paul

1. Junior Resident, Department of General Surgery, SRM Institute of Science and Technology, Chengalpattu, Tamil Nadu, India. 2. Associate Professor, Department of General Surgery, Trichy SRM Medical College Hospital and Research Centre, Trichirapalli, Tamil Nadu, India. 3. Associate Professor, Department of General Surgery, SRM Institute of Science and Technology, Chengalpattu, Tamil Nadu, India. 4. Professor, Department of General Surgery, SRM Institute of Science and Technology, Chengalpattu, Tamil Nadu, India. 5. Assistant Professor, Department of General Surgery, SRM Institute of Science and Technology, Chengalpattu, Tamil Nadu, India.

Correspondence Address :
R Lakshmana,
SRM Nagar, Potheri, Kattankulathur, Chengalpattu, Tamil Nadu, India.
E-mail: drlaksh31@gmail.com

Abstract

Introduction: Among the hospital acquired infections, Surgical Site Infection (SSI) still remains as the major problem for surgeons. Inguinal hernia surgeries are considered as clean surgeries, incidence of SSI in posthernioplasty is found to be 3.1%-4.5%. However, in tertiary care centres in developing countries like India, the incidence is found to be high at 11-14%.

Aim: The aim of the present study was to compare the efficacy of preoperative single dose ceftriaxone infiltration at the incision site and preoperative Intravenous ceftriaxone only in preventing SSI in hernioplasty.

Materials and Methods: A prospective interventional study was conducted at SRM Medical College and Research Institute, Chengalpattu, Tamil Nadu, from May 2021 to October 2022 for a duration of 18 months in 100 Patients, who attended the surgical outpatient block or other known cases of inguinal hernia who were referred to the surgery department from other departments. They were divided into group A or group B randomly. Hernioplasty was done on these groups, preoperative, intraoperative and postoperative wound swab was sent for these patients. Postoperatively patients were followed-up on 3rd, 7th and 14th day and assessed for development of SSI. The continuous variables were presented as mean and SD. The categorical variables were expressed in percentages. The significance of continuous scale data between two groups were determined using student t-test. The Chi-square/Fischer’s-exact test was used to evaluate the significance of the categorical data analysed. Data analysis was computed using Statistical Package for Social Sciences (SPSS) version 27 and Microsoft excel office 2019.

Results: Male preponderance was seen 91% in inguinal hernias. Most of the patients belonged to the age group of 41-60 (54%) years of age. Ten patients (20%) developed SSI who got i.v. antibiotic injection but only three patients (6%) developed SSI who got intraincisional antibiotic injection with a p-value of 0.037 (<0.05) showing significance. One patient developed haematoma for with re-exploration was done on Postoperative Day (POD) #3. Two patients developed wound gapping for which secondary suturing was done on POD #7 and suture removal was done on POD #21. For rest of the all the patient’s suture removal was done on POD #14. Intraopertive and postoperative and organism growth was seen only in the 13 patients who developed SSI. Most common organism isolated was staph, Aureus (38.5%, 5 cases). All 13 patients who developed SSI had some co-morbidity. Out of the 13 patients who developed SSI 11 patients (84%) had surgery for more than 30 minutes. Mean hospital stay was 3-5 days (87%).

Conclusion: In the present study, there was significant reduction in incidence of SSI in the group, that received preoperative single dose Intraincisional ceftriaxone than the other group that received only preoperative intravenous ceftriaxone. Preoperative intraincisional antibiotics significantly reduces the rate of SSI because of the higher concentration achieved at the incision site.

Keywords

Antibiotics, Complication, Efficacy, Hernia, Infection, Inguinal, Mesh, Postoperative, Surgical wound

Among the hospital acquired infections 33% are due to Surgical Site Infection. SSI still continues to be a major problem for surgeons as it not only increases the hospital stay but also affects the postoperative outcome of the patients. It not only affects the surgeon and patients but also adds on to the economic burden for patient and for the country (1). Ninety percent of the SSI occurs within 30 days of surgery, most commonly 5 to 6 days of postoperative period. The organisms get introduced through the wound during the decisive period. In order to prevent surgical site contamination surgical prophylaxis is must, as its main goal is to ensure ideal tissue concentration of drug have a reasonable broad-spectrum activity against expected organisms is maintained during the decisive period (2). Failure to maintain this leads to increased chances of SSI. Polk HC Jr et al., has emphasised that efficacy of the antibiotic agent for prophylaxis of SSI is based on wounds levels and not blood or serum levels (3).

After a breach in the tissue either due to trauma or surgery, it takes 4 hours interval before bacterial growth gets established to cause an infection this is called decisive period (4). Preoperative intraincisional injection helps to achieve this high tissue levels. So, the need of the hour is to achieve high target tissue concentrations of desired antibiotic based on microbiological prevalence of organisms in clean, contaminated, and dirty surgical incisions (4). It is not advisable to use the antibiotic for a prolonged period, because of the emergence of multidrug resistant strains (5). Hernioplasty surgeries are considered as clean surgeries and the incidence of SSI in open hernia surgeries are found to be 3.1% to 4.5% (6), but in tertiary care centres in developing countries like India SSI for clean surgeries are found to be high 10-14% (7),(8), due to various factors like preoperative care, theatre environment, postoperative care, lesser concentration of antibiotic at the incision site, use of synthetic (prolene) mesh, fibrin matrix formed at the incision site, and improper timing of administration of the antibiotics. Hence, antibiotic prophylaxis has become a must in inguinal hernia surgeries (9). Antibiotic prophylaxis in open hernioplasty has proved to reduce the incidence of SSI by 50%, in this study, a novel technique has been used which is single dose intraincisional infiltration of antibiotic, there are studies over the past decade that has showed positive outcome for intraincisional infiltration of ceftriaxone, but all those studies had a postoperative antibiotic coverage (8),(9),(10).

Thus, the aim of the present study was to compare the “efficacy of preoperative single dose ceftriaxone infiltration at the incision site and preoperative Intravenous ceftriaxone only in preventing SSI in hernioplasty”.

Material and Methods

A prospective interventional study was conducted at SRM Medical College and Research Institute, Chengalpattu, Tamil Nadu, India, from May 2021 to October 2022. 100 patients were included, with 50 in each group, who attended the surgical outpatient block or referred to the department who were known case of Inguinal hernia. Prior clearance was obtained from the Institutional Ethical Committee vide letter no 2827/IEC/2021.

Sample size calculation:

Formula: n=(Za+Z1-b)2 (P1Q1+P2Q2)

(P1-P2)2

P1=25% in patients who received intra-venous injection; P2=5% in patients who received intraincisional infiltration; Q=(100-P); Zα+Z1-β=3.92
Prevalence was calculated based a study by Singh A et al., (8).

Where,
P1=developed SSI in group A
P2=developed SSI in group B
Q1=not developed SSI in group A
Q2=not developed SSI in group B
=7.84 (1875+475)
400
=46.1˜50 in each group

Patients were randomly allocated with odd numbers in group A and even numbers in group B in the order of admission to each group (single dose of intravenous ceftriaxone (1 gm) vs intraincisional ceftriaxone before starting procedure) following which patients were followed-up on outpatient basis for a period of four weeks.

Inclusion criteria: The inclusion criteria were patients more than 18 years of age (male/female) undergoing open hernioplasty at our tertiary care centre who showed nil allergy to test dose (ceftriaxone) and who are ready to take part in the study and accepting the informed consent were included and those who belonged to ASA I/II category (11).

Exclusion criteria: Patients who were excluded from this study where those who did not consent for the study and those who had incisional hernias, recurrent hernias, inguinal hernias with complications like irreducibility, obstruction, strangulation, incarceration and laparoscopic hernia repair and those who are allergic to ceftriaxone test dose and those had a prior incidence of SSI and patients who are suffering from liver failure, immunocompromised or prolonged steroid therapy and those who belonged to ASA III/IV.

A proper clinical history with examination and informed consent, Injection ceftriaxone, 10 mL distilled water supplied in the hospital and Microbiology lab requisition form for pus culture and sensitivity. All patients with inguinal hernia in an elective setting were included after obtaining written informed consent. Patients were randomised into two groups by allotting random numbers.

Group A: Prophylaxis by intraincisional Infiltration of the Antibiotic (1 gram of Ceftriaxone diluted with 10 mL of distilled water was 2infiltrated along the site of proposed incision 20 minutes before incision after induction by the anaesthetist).

Group B: A single dose of one gram of Ceftriaxone was administered intravenously 20 minutes before the surgical incision at the time of induction of anaesthesia.

Study Procedure

The dose of antibiotic used for infiltration was one gram of Ceftriaxone (Injection XONE 1 gm) dissolved in 10 mL of distilled water (whose concentration of ceftriaxone equals to 100 mg/mL) was infiltrated 20 minutes prior to incision, uniformly around all the margins of the planned incision with a disposable syringe and 16 Gauge (G) needle in subcutaneous tissue plane, after giving Inj. Ceftriaxone intra dermal test dose, to check for allergic reaction. Preoperative, intraoperative and postoperative local tissue samples were sent for culture and sensitivity, operation site was covered by sterile occlusive dressings for 72 hours for elective cases, then first inspection of the suture site was carried out. The suture site was left open thereafter to inspect daily except in patients who developed infection. SSI is assessed by complication like wound discharge, infection and wound dehiscence and classified as serous, seropurulent and purulent discharge. Cases where SSI was suspected, occlusive dressing was resorted to twice daily wound wash with normal saline and betadine. Wound complications were documented as per Centres for Disease Control and Prevention (CDC) guidelines 2017 (12). Postoperative wound infection was categorised into superficial, deep and organ space based on CDC guidelines (13). Patients developing any discharges from the surgical wound were investigated by pus swabs for culture and appropriate antibiotics were administered intravenously as per culture and sensitivity report. Alternate sutures were removed on 10th postoperative day. Complete suture removal on 14th postoperative day. Subsequently, all cases were followed-up in the general surgery Outpatient Department (OPD) at weekly intervals for one month.

Intraoperative blood loss was estimated using Gauze Visual Analogue (GVA), less than 50 mL was considered as minimal blood loss, 50-100 mL was considered as moderate blood loss and more than 100ml was considered as severe blood loss for open hernioplasty (14). Postoperative pain was assessed using Visual Analogue Scale (VAS), as no pain (score 0), mild pain (1-3), moderate pain (4-6), severe pain (7-9), very severe pain (10) (15). Parameters studied were age distribution, gender distribution, development of SSI in intraincisional infiltration vs intravenous infiltration, type of SSI and complications and how were they managed, duration of surgery, organisms isolated, intraoperative blood loss, postoperative pain, mean hospital stay and influence of co-morbid in preventing SSI.

Statistical Analysis

The continuous variables were presented as mean and SD. The categorical variables were expressed in percentages. The significance of continuous scale data between two groups were determined using student t-test. The Chi-square/Fischer’s-exact test were used to evaluate the significance of the categorical data analysed, p-value of less than 0.05 was taken significant. Null hypothesis stated that there was no relation between intraincisional infiltration and prevention of SSI, null hypothesis was accepted as true if p-value is >0.05 and rejected if p-value is <0.05. SPSS version 27 and Microsoft excel version office 2019 was used to compute the data.

Results

Majority of the patients belonged to the age group of 41-60 years of age comprising 54% of total number of cases (Table/Fig 1).

There was a male preponderance of 91% and female patients of 9%. Showing that inguinal hernias are more common in males (Table/Fig 2). Among the patients who had single intraincisional infiltration only three patients that is 6% (3/50) developed SSI. But in patients who have single dose intravenous injection 10 patients that is 20% (10/50) developed SSI (Table/Fig 3).

On tabulating the findings in a Chi-square test, there was an association between group A and group B in preventing SSI. The p-value 0.037 which is <0.05 so, the null hypothesis was rejected (Table/Fig 4).

Based on the type of infection (Table/Fig 5), 87 patients had no SSI among which 47 patients that is 54% belonged to patients who had intraincisional infiltration and 40 patients that is 46% belonged to patients who had intravenous injection. Ten patients had superficial infection (discharge from wound site) out of which three patients (30%) belonged to group A and seven patients (70%) belonged to group B. Three patients had deep infection (two patients had wound gapping and one patient had haematoma collection) out of which all three patients belonged to all three patients belonged to group B and none of the patients of group A had moderate infection.

Among the 3 patients who had deep infection, one patient developed haematoma for with re-exploration was done on POD #3 (Table/Fig 6). Two patients developed wound gapping for which secondary suturing was done on POD #7 (Table/Fig 7) and suture removal was done on POD #21. For rest of the all the patient’s suture removal was done on POD #14.

Comparing the duration of surgery, 81 patients had surgery in less than 30 minutes, in which 44 patients (54%) belonged to group A and 37 patients (58%) belonged to group B, in which two patients of group B (4%) developed SSI.

Nineteen patients had surgery between 30 minutes to two hours, in which six patients (31%) belonged to group A and 13 patients (68%) belonged to group B. Three patients belonging to group A (50%) developed SSI and 8 patients belonging to group B (61%) developed SSI. None of the patients had surgery for more than two hours. Out of the 13 patients who developed SSI 11 patients (84%) had surgery for more than 30 minutes (Table/Fig 8). This study found that duration of surgery was statistically significantly in group A (23.40±8.41) compared with group B (36.80±28.95), p=0.003*. Hence, the average duration of surgery of group A is better than group B. There is an association between the duration of surgery and development of SSI (Table/Fig 9).

Wound culture sensitivity was sent preoperative, intraoperative and postoperative and organism growth was seen only in the 13 patients who developed SSI. Most common organisms isolated were staph. Aureus (38.5%), enterococcus (23%) and E.coli (15%). Most common antibiotics sensitive to the organisms were: (1) Ceftriaxone; (2) Amikacin; and (3) Piperacillin (Table/Fig 10),(Table/Fig 11).

In estimating the blood loss based on GVA (Table/Fig 12), 72 patients had nil blood loss out of which 38 patients (52%) belonged to group A and 34 patients (47%) belonged to group B. Twenty seven patients had minimal blood loss (<50 mL), of which 12 patients (44%) belonged to group A and 15 patients (56%) belonged to group B. One patient had moderate blood loss (50-100 mL) belonging to group B. The p-value was found to be 0.459, hence, there here was no association found between type of infiltration and control of intraoperative blood loss.

Chi-square test upon comparing the postoperative pain (Table/Fig 13), 84 patients had mild pain out of which 43 patients (51%) belonged to group A and 41 patients (49%) belonged to group B. Sixteen patients had moderate pain out of which seven patients (44%) belonged to group A and nine patients (56%) belonged to group B. There was no significant difference between two groups in controlling postoperative pain (p>0.05).

In this study, out of the 100 patients, 87 patients had a mean hospital stay of 3-5 days including 47 patients of group A and 40 patients of group B. Ten patients were found to have a hospital stay of 1-2 weeks including three patients of group A who developed SSI and seven patients of group B who developed SSI for daily dressing. Three patients of group B had a hospital stay of more than two weeks, among which two patients had to undergo secondary suturing for wound gapping and one patient had to undergo re-exploration and haematoma evacuation followed by secondary suturing (Table/Fig 14).

This study found that hospital stay was statistically significantly in group B (3.48±3.79) compared with group A (2.28±1.76), t(98)=2.029, p=0.046*. Hence, the average hospital stay of group A is better than group B (Table/Fig 15).

Among 100 patients, 52 patients had co-morbidities out of which 27 patients (52%) belonged to group A and 25 patients (48%) belonged to group B. All 13 patients who developed SSI had co-morbidities in both group A and group B p-value is 0.047. Three patients in group A developed SSI among the 27 patients that is 11%. Ten patients in group B developed SSI among the 25 patients that are 40%.

The SSI was found to be more prevalent in patients who had more than one co-morbidity (T2DM/SHTN & T2DM/SHTN/Obesity) that is 82.5% (Table/Fig 16). There was an association between presence of multiple co-morbidities and development of SSI.

Intraincisional infiltration has a protective effect in developing SSI compared to intravenous injection.

Discussion

The surgical site infection is the most common complication following any surgical procedure. Based on the study done by Sikora A and Zahra F on nosocomial infections, SSI is the third most common cause of nosocomial infection (16). This study has been carried out in the tertiary care centre for 18 months from the month of May 2021 to October 2022. Risk of SSI is 23% to 38% in India (17) which is higher in compared to global estimate of 0.5% to 15% due to various factors like preoperative care, the theatre environment, postoperative care, and the type of surgery. In the present study, 100 patients were included who were divided into two groups with n=50 in each group, group A patients received preoperative single dose intraincisional infiltration of ceftriaxone and group B included the patients who received preoperative single dose intravenous infiltration of ceftriaxone and outcomes were studied preoperative, intraoperative and postoperative.

Among the 100 patients studied, majority of the patients belonged to the age group of 41-60 years of age comprising of about 54 that is 54% based on cross tabulation which was in concordance with the study done by Sayanna S on prevalence of inguinal hernias in Indian population which showed higher incidence in age group of 41-60 years of age accounting to about 53.5% (18). On comparing the gender distribution, male preponderance of 91% and female patients of 9%. With a male: female ratio of 10.1:1. A study conducted by Berndsen MR et al., on Inguinal hernias showed that male to female ratio of 9:1 showing that inguinal hernias are more common in males than females (19). Inguinal hernia surgeries are considered as clean surgeries, incidence of SSI in posthernioplasty patients was found to be 3.1%-4.5% (6). But, in tertiary care centres in developing countries like India incidence is found to be high. In a study conducted by Alagarsamy GS and Ramasamy R on efficacy of antibiotic prophylaxis in preventing SSI in patients undergoing Lichtenstein’s hernioplasty in a tertiary care centre SSI incidence was found to be 14% (7). In another study done by Singh A et al., on comparative study of preoperative intraincisional infiltration of ceftriaxone vs. intravenous ceftriaxone for prevention of SSI clean cases had a SSI rate of 11%, these findings are consistent with the present study, this may be due to various factors like preoperative care, the theatre environment, postoperative care, lesser concentration of antibiotic at the incision site, fibrin matrix formed at the incision site, and improper timing of administration of the antibiotics (8). Hence, antibiotic prophylaxis has become a must in inguinal hernia surgeries. In this study, among the patients who had preoperative single dose intraincisional infiltration of ceftriaxone 6% (3 patients) developed SSI. Among the patients who had preoperative single dose intravenous injection of ceftriaxone 20% (10 patients) developed surgical site injection. On statistically analysing the above findings, it is found that, there was a significant association between group A and group B in preventing SSI. The p-value 0.037 (<0.05, hence this proves that intraincisional infiltration was better than intravenous injection in preventing SSI. Based on the type of post-op complication it was observed that intraincisional infiltration is better in preventing postoperative complication than intravenous group.

In comparing the duration of surgery, Cheng H et al., in his study on prolonged operative duration increases risk of SSI proves that increase in operative time increases the risk of SSI like 13%, 17%, and 37% increased likelihood for every 15 minutes, 30 minutes, and 60 minutes of surgery, respectively (20). These findings are consistent with the present study out of the 13 patients who developed SSI, 11 patients (84%) had surgery for more than 30 minutes. Association was found between development of SSI and prolonged duration of surgery as p-value (0.003*) was found to be significant. In this study, based on the culture sensitivity, most common organism isolated was staphylococcus aureus 38.5% (five patients), next was enterococcus 23% (three patients) and Escherichia coli 15% (two patients). And most common antibiotic sensitive was ceftriaxone followed by amikacin and piperacillin. In similar studies done by Singh A et al., showed that Escherichia coli were found to be common 72%; in another study done by Kamat US et al., noticed that pseudomonas (40%) is most identified organism from surgical site (8),(21).

In estimating the blood loss based on GVA scale, 72 patients had nil blood loss in both case (52%) and control (47%) groups. Twenty seven patients had minimal blood loss of which 44% (12 patients) belong to case and 56% (15 patients) belonged to control group. One patient in control group had a moderate blood loss. In a study done by Aeschbacher P et al., showed that blood loss >100 mL and open surgery are independent risk factors for SSI (22). In this study on statistical analysis there was no significance found in control of intraoperative blood loss as most of the patients had nil to minimal blood loss. Postoperative pain was assessed using VAS, 84 patients had mild pain in both case (51%) and control groups (49%). Sixteen patients had moderate pain out of which seven patients (44%) belonged to group A and nine patients (56%) belonged to group B. There is no significant difference between two groups in controlling postoperative pain.

In the present study, on statistical analysis of mean hospital stay, average hospital stay of case was better than control group which denotes that postoperative recovery was better and faster in patients who had infiltration in compared with patients who had intravenous which was in concordance with the study done by Singh A et al., and the study done by Totty JP et al., (8),(23). On assessing influence of co-morbidities, it was found that SSI was found to be more prevalent in patients who had more than one co-morbidity (T2DM/SHTN & T2DM/SHTN/OBESITY) that is 82.5 % of those who had multiple co-morbidities. There is an association found between multiple co-morbidities and development of SSI. Intraincisional infiltration has a protective effect in developing SSI compared to intravenous injection. This is found to be in accordance with many studies that prove the influence of co-morbidities in development of SSI (24),(25). Among the prompted newer modes of administering prophylactic antibiotics, one of which is the intraincisional infiltration of the antibiotic to ensure a higher concentration of the antibiotic at the incision site.

Limitation(s)

Incision time was delayed as surgeon has to wait for 20 minutes after local infiltration. Factors like concentration of the antibiotic in the blood and at incisional site at various intervals, affinity of the antibiotic to adipose tissue were not studied in this study. This can be established in a larger study where these factors are considered.

Conclusion

In this study, the group that received single dose intraincisional ceftriaxone preoperatively had significant reduction in the incidence of SSI than the group which received single dose intravenous ceftriaxone preoperatively in hernioplasty surgeries. This can be adapted in surgical procedures as it is an easier mode of administration.

References

1.
Sattar F, Sattar Z, Zaman M, Akbar S. Frequency of postoperative surgical site infections in a tertiary care hospital in Abbottabad, Pakistan. Cureus. 2019;11(3):e4243. Published 2019 Mar 12. Doi: 10.7759/cureus.4243. [crossref]
2.
Crader MF, Varacallo M. Preoperative antibiotic prophylaxis. StatPearls, StatPearls Publishing, 4 September 2022.
3.
Polk HC Jr, Lopez-Mayor JF. Postoperative wound infection: A prospective study of determinant factors and prevention. Surgery. 1969;66 (1):97-103.
4.
O’Connell PR, McCaskie AW, Williams NS. (Eds.). (2018). Bailey & Love’s Short Practice of Surgery, 27th Edition (27th ed.). CRC Press. https://doi. org/10.1201/9781315111087.
5.
Llor C, Bjerrum L. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem. Therapeutic advances in drug safety. 2014;5(6):229-41. https://doi.org/10.1177/2042098614554919. [crossref][PubMed]
6.
Sanchez-Manuel FJ, Lozano-García J, Seco-Gil JL. Antibiotic prophylaxis for hernia repair. The Cochrane Database of Systematic Reviews. 2012;2:CD003769. 15 Feb. 2012. Doi: 10.1002/14651858.CD003769.pub4. [crossref][PubMed]
7.
Alagarsamy GS, Ramasamy R. The efficacy of antibiotic prophylaxis in preventing SSI (surgical site infection) in patients undergoing Lichenstein’s hernioplasty at our tertiary care centre. International Surgery Journal [Online]. 2017;4(6):1922-25. [crossref]
8.
Singh A, Salim M, Singh B, Akshita. A comparative study of preoperative intraincisional infiltration of ceftriaxone vs. intravenous ceftriaxone for prevention of surgical site infections. International Surgery Journal [Online], 2019;6(5):1686-92. [crossref]
9.
Sivachandran, K (2017). An experimental study comparing preoperative intraincisional antibiotic infiltration and prophylactic intravenous antibiotic administration for reducing surgical site infection in laparotomy surgeries. Madurai Medical College, Madurai. http://repository-tnmgrmu.ac.in/id/eprint/12298.
10.
Sanabria A, Domínguez LC, Valdivieso E, Gómez G. Prophylactic antibiotics for mesh inguinal hernioplasty: A meta-analysis. Ann Surg. 2007;245(3):392- 96. Doi: 10.1097/01.sla.0000250412.08210.8e. PMID: 17435546; PMCID: PMC1877016. [crossref][PubMed]
11.
Daabiss M. American Society of Anaesthesiologists physical status classification. Indian Journal of Anaesthesia. 2011;55(2):111-15. Doi: 10.4103/0019-5049.79879. [crossref][PubMed]
12.
Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surgery. 2017;152(8):784-91. Doi: 10.1001/ jamasurg.2017.0904. [crossref][PubMed]
13.
Reichman DE, Greenberg JA. Reducing surgical site infections: A review. Reviews in Obstetrics & Gynecology. 2009;2(4):212-21.
14.
Ali Algadiem E, Aleisa AA, Alsubaie HI, Buhlaiqah NR, Algadeeb JB, Alsneini HA. Blood loss estimation using gauze visual analogue. Trauma Mon. 2016;21(2):e34131. Published 2016 May 3. Doi: 10.5812/traumamon.34131. [crossref][PubMed]
15.
DeLoach LJ, Higgins MS, Caplan AB, Stiff JL. The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesth Analg. 1998;86(1):102-06. Doi: 10.1097/00000539- 199801000-00020. [crossref]
16.
Sikora A, Zahra F. Nosocomial Infections. Stat Pearls, StatPearls Publishing, 23 September 2022.
17.
Vatavati SR, Kampli MS. Surgeries and surgical site infection in India: An analysis of health management information system 2019-2020. J Surg Surgical Res. 2020;6(2):146-48. Doi: https://dx.doi.org/10.17352/2455-2968.000118. [crossref]
18.
Sayanna S. Prevalence of inguinal hernia in Indian population a retrospective study. MedPulse- International Medical Journal. 2015;2(2):75-78. http://www. medpulse.in.
19.
Berndsen MR, Gudbjartsson T, Berndsen FH. [Inguinal hernia-review]. Laeknabladid. 2019;105(9):385-91. Icelandic. Doi: 10.17992/lbl.2019.09.247. PMID: 31482863. [crossref][PubMed]
20.
Cheng H, Chen BP, Soleas IM, Ferko NC, Cameron CG, Hinoul P. Prolonged operative duration increases risk of surgical site infections: A systematic review. Surg Infect (Larchmt). 2017;18(6):722-35. Doi: 10.1089/sur.2017.089. [crossref][PubMed]
21.
Kamat US, Fereirra AM, Kulkarni MS, Motghare DD. A prospective study of surgical site infections in a teaching hospital in Goa. Indian J Surg. 2008;70(3):120-24. Doi: 10.1007/s12262-008-0031-y. [crossref][PubMed]
22.
Aeschbacher P, Nguyen TL, Dorn P, Kocher GJ, Lutz JA. Surgical site infections are associated with higher blood loss and open access in general thoracic practice. Front Surg. 2021;8:656249. Published 2021 Jun 25. Doi: 10.3389/ fsurg.2021.656249. [crossref][PubMed]
23.
Totty JP, Moss JWE, Barker E, Mealing SJ, Posnett JW, Chetter IC, et al. The impact of surgical site infection on hospitalisation, treatment costs, and health-related quality of life after vascular surgery. International Wound Journal. 2021;18(3):261-68. Doi: 10.1111/iwj.13526. [crossref][PubMed]
24.
Ansari S, Hassan M, Barry HD, Bhatti TA, Hussain SZM, Jabeen S, et al. Risk factors associated with surgical site infections: A retrospective report from a developing country. Cureus. 2019;11(6):e4801. Doi: 10.7759/cureus.4801. PMID: 31396469; PMCID: PMC6679712. [crossref]
25.
Cheadle WG. Risk factors for surgical site infection. Surgical Infections. 2006;7(Suppl 1):S7-11. Doi: 10.1089/sur.2006.7.s1-7.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/60685.17732

Date of Submission: Oct 10, 2022
Date of Peer Review: Dec 08, 2022
Date of Acceptance: Feb 07, 2023
Date of Publishing: May 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Oct 13, 2022
• Manual Googling: Jan 06, 2023
• iThenticate Software: Feb 06, 2023 (16%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com